ABBVIE INC. (ABBV)
Clinical trial NCT03105102 updates: 1. completion date: 2026-05-01 → 2029-02-01 2. primary completion date: 2026-05-01 → 2029-02-01
Clinical trial NCT03105102 updates: 1. completion date: 2026-05-01 → 2029-02-01 2. primary completion date: 2026-05-01 → 2029-02-01
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical